1. Home
  2. KDLY vs SNGX Comparison

KDLY vs SNGX Comparison

Compare KDLY & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KDLY
  • SNGX
  • Stock Information
  • Founded
  • KDLY 2019
  • SNGX 1987
  • Country
  • KDLY United States
  • SNGX United States
  • Employees
  • KDLY N/A
  • SNGX N/A
  • Industry
  • KDLY
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KDLY
  • SNGX Health Care
  • Exchange
  • KDLY NYSE
  • SNGX Nasdaq
  • Market Cap
  • KDLY 19.6M
  • SNGX 7.4M
  • IPO Year
  • KDLY 2024
  • SNGX 1987
  • Fundamental
  • Price
  • KDLY $2.89
  • SNGX $2.39
  • Analyst Decision
  • KDLY
  • SNGX
  • Analyst Count
  • KDLY 0
  • SNGX 0
  • Target Price
  • KDLY N/A
  • SNGX N/A
  • AVG Volume (30 Days)
  • KDLY 12.8M
  • SNGX 44.9K
  • Earning Date
  • KDLY 02-25-2025
  • SNGX 03-14-2025
  • Dividend Yield
  • KDLY N/A
  • SNGX N/A
  • EPS Growth
  • KDLY N/A
  • SNGX N/A
  • EPS
  • KDLY N/A
  • SNGX N/A
  • Revenue
  • KDLY $2,875,400.00
  • SNGX $364,183.00
  • Revenue This Year
  • KDLY N/A
  • SNGX N/A
  • Revenue Next Year
  • KDLY N/A
  • SNGX $76.64
  • P/E Ratio
  • KDLY N/A
  • SNGX N/A
  • Revenue Growth
  • KDLY N/A
  • SNGX N/A
  • 52 Week Low
  • KDLY $0.65
  • SNGX $1.83
  • 52 Week High
  • KDLY $5.25
  • SNGX $14.88
  • Technical
  • Relative Strength Index (RSI)
  • KDLY N/A
  • SNGX 43.83
  • Support Level
  • KDLY N/A
  • SNGX $2.25
  • Resistance Level
  • KDLY N/A
  • SNGX $2.60
  • Average True Range (ATR)
  • KDLY 0.00
  • SNGX 0.15
  • MACD
  • KDLY 0.00
  • SNGX 0.03
  • Stochastic Oscillator
  • KDLY 0.00
  • SNGX 52.27

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: